liver cirrhosis: insights to risk factors, clinical presentation and outcome Article in International Journal of Advanced Research 3(12):1539-1548 · December 2015 1st Afifi F Afifi 2nd Osama Basha 6.99 · Zagazig University + 1 3rd Fady Maher Zagazig University Last Raghda Abd Ellatif Hafez 16.2 · Faculty of medicine/Zagazig University.www.zu.edu.eg Show more authors 3 elements are still missing from your publication Add figures Publications with figures get 2 times more reads than papers without
treatment and therapies for liver disease. One potential solution to the dilemma of curative treatment for liver disease is the emerging development and utilization of nanotechnology strategies for more effective liver disease diagnosis and therapy. This paper will propose using targeted liposomes as a system for delivering siRNA to hepatic stellate cells to impede and ultimately treat liver fibrosis. The Growing Problem of Liver Cancer and Liver Fibrosis As the number of deaths from liver cancer are increasing
power,” two sayings that are used frequently. Yet, if you are in the medical field, it is risky to lay lives down, including your own, for an ‘I didn’t know.’ There are several reasons why I chose Hepatitis C for my research paper, but the main reason is Hepatitis C and Cirrhosis took a very special life away from me due to ignorance. With the medical field evolving everyday, there are some medical professionals that have conservative points-of-view and have become dormant learners. As EMS professionals
According to United Network for Organ Sharing (2010) organ donations and transplantation are the removal of organs and tissues from one person and placed into another person’s body. The need for organ transplantation usually occurs when the recipient organ has failed (UNOS, 2010). Organ donation can save the lives of many individuals who are on the waiting list for an organ donation. Becoming an organ donor can be a difficult decision. Many people have the false beliefs about being an organ donor
November 19, 2000 Research Paper Elizabeth Antalek One out of thirteen adults are considered to be an alcoholic or suffer from a drinking problem. Today, fourteen million Americans suffer from a disease that is caused by a combination of physiological, psychological, social, and genetic factors. Alcoholism is a developmental disease that progresses slowly over a number of years and is based on both the physical and emotional dependency on alcohol. In many cases it leads to brain damage
consumption varies markedly. Individuals admitted for the first time to an alcoholism treatment center typically have been consuming 3–4 oz (80–100 g) of pure alcohol per day, corresponding to seven to nine drinks or bottles of beer or glasses of wine. Studies have shown that problem drinking in these populations starts at about 2 oz/day (60 g/day), that is, four to five drinks per day, and that these are consumed in rapid succession, leading to intoxication on three or more days per week. Individuals who
In the present study, males outnumbered females (M/F 63/7) with the average age at presentation being 45.38±12.1 years. This findings were similar to the results obtained in studies by Sharma et al who found the presenting age to be 44.0 ± 11.4 years with higher incidence in males ( M:F:75:16) 8. The errors on NCT-A tend to increase with age 9, but as the mean age of the patients was 45.38±12.1 years in this study, this was not considered to significantly influence the results. Alcoholism was the
America (IDSA) and the American Associations for the Study of Liver Diseases (AASLD). The criteria of who should receive the treatment include how much the virus in the body, the strain of hepatitis C, the degree of liver inflammation or damage, comorbidity, and response to previous treatment (Infectious Diseases Society of America [IDSA], 2016). The highest priority for treatment should give to a patient with advanced fibrosis and compensated cirrhosis (IDSA, 2016). Moreover, treatment priority should
America (IDSA) and the American Associations for the Study of Liver Diseases (AASLD). The criteria of who should receive the treatment include how much the virus in the body, the strain of hepatitis C, the degree of liver inflammation or damage, comorbidity, and response to previous treatment (Infectious Diseases Society of America [IDSA], 2016). The highest priority for treatment should give to a patient with advanced fibrosis and compensated cirrhosis (IDSA, 2016). Moreover, treatment priority should
MACHINE LEARNING APPROACH FOR PREDICTING STAGES OF CHRONIC KIDNEY DISEASE ABSTRACT Chronic kidney disease refers to the kidneys have been damaged by conditions, such as diabetes, glomerulonephritis or high blood pressure. It also creates more possible to mature heart and blood vessel disease. These problems may happen gently, over a long period of time, often without any symptoms. It may ultimately lead to kidney failure requiring dialysis or a kidney transplant to preserve survival time. So